Voya Investment Management LLC Chinook Therapeutics, Inc. Transaction History

Voya Investment Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$18.66 - $38.58 $78,558 - $162,421	4,210 Added 22.48%	22,939 $881,000
Q3 2022 Nov 14, 2022	BUY	$17.51 - $23.37 $40,465 - $54,008	2,311 Added 14.08%	18,729 $368,000
Q2 2022 Aug 15, 2022	BUY	$12.59 - $18.8 $23,291 - $34,780	1,850 Added 12.7%	16,418 $287,000
Q1 2022 May 16, 2022	BUY	$12.02 - $16.69 $18,378 - $25,519	1,529 Added 11.73%	14,568 $238,000
Q4 2021 Feb 14, 2022	BUY	$10.69 - $16.83 $6,349 - $9,997	594 Added 4.77%	13,039 $213,000
Q2 2021 Aug 16, 2021	SELL	$13.6 - $18.98 $21,229 - $29,627	-1,561 Reduced 11.15%	12,445 $176,000
Q4 2020 Feb 16, 2021	BUY	$11.9 - $20.91 $166,671 - $292,865	14,006 New	14,006 $222,000

234K

Ticker KDNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,896,300
Description
Chinook Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of precision medicines for kidney diseases. The company's lead clinical program is atrasentan, a Phase III endothelin receptor antagonist for the treatment of IgA nephropathy and other proteinuric glomerular diseases. ...

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Voya Investment Management LLC with notifications on news.